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Summary. CD44 is an integral membrane glycoprotein 
that has diverse functions in cell-cell and cell-substrate 
interactions. It has been suggested that it may be a 
determinant of metastatic and invasive behavior in 
carcinomas. The immunohistochemical expression of 
CD44 was examined in a series of 34 squamous cell 
carcinomas, 13 in situ carcinomas, 35 cases with various 
degrees of epithelial dysplasia, 10 papillomas and 17 
cases of keratosis. We used the monoclonal mouse anti- 
human phagocytic glycoprotein-1 CD44 (clone DF 
1485), on formalin-fixed, paraffin-embedded tissue. 
CD44 expression was correlated with the expression of 
Rb and p53 proteins, with the proliferative indices Ki-67 
and PCNA as well as with conventional clinico- 
pathological data. The mean value of CD44 expression 
was 78.84 in squamous cell carcinomas, 78.04 in in situ 
carcinomas, 54.93 in dysplasia, 26.8 in papillomas and 
24.97 in keratosis. There was no significant difference of 
CD44 expression between in situ and invasive 
carcinomas. However, a strong difference of reaction 
between carcinomas and the other cases was observed. 
CD44 expression was statistically higher in dysplastic 
lesions than the cases of keratosis (p<0.0001) and 
papillomas (p=0.01) .  In the group of invasive 
carcinomas, CD44 expression was statistically correlated 
with pRb (p=0.011), while in preinvasive lesions it was 
correlated with PCNA (p=0.016). The relationship with 
the degree of dysplasia or grade of carcinoma and p53 
protein expression was insignificant. 
These observations suggest that CD44 expression 
may be involved in the multiple mechanism of the 
development and progression of laryngeal lesions and 
may help to predict the risk of transformation of the 
benign or precancerous lesions to cancer. 
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lntroduction 
CD44 is a multifunctional integral cell membrane 
glycoprotein, expressed in epithelial, mesenchymal and 
hematopoietic cells (Jackson et al., 1994) and implicated 
in such diverse biological processes, such as lymphocyte 
recirculation and activation, and cell-cell and cell-matrix 
interactions (Bartolazzi et al., 1994). It is a widely- 
distributed receptor type protein which exists as a 
standard form (CD44H) and as various isoforms 
generated by alternative splicing of the products of at 
least 10 variant exons (Fox et al., 1994). Overexpression 
of whole CD44 or some splice variants has been found 
in various types of human tumours and is supposed to be 
implicated in tumour progression (Wielenga et al., 1993; 
Fox et al., 1994). Elevated CD44 expression has also 
been observed in metastatic deposits (Matsumura and 
Tarin, 1992) and data from animal experiments have 
suggested that overexpression of isoforms containing 
exon 11 (v6) could be involved in the metastatic process 
(Gunthert et al., 1991; Fox et al., 1994). 
CD44 has been associated with proliferation, 
suggesting that it has a role in tumour cell growth (Alho 
and Underhill, 1989; Abbasi et al., 1993) and has been 
recently associated with expression of mutant p53 
protein in colorectal tumourigenesis (Mulder et al., 
1995). To our knowledge, there are a few studies of 
CD44 expression in laryngeal lesions, and those there 
are have controversia1 results (Spafford et al., 1996; 
Ostwald et al., 1997; Sugar et al., 1997). Therefore, the 
role of CD44 is currently unknown. 
In the present study, we evaluated the immunohisto- 
chemical expression of the CD44 molecule in a series of 
hyperplastic, premalignant and malignant lesions of the 
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larynx in order to determine its role during larynx- 
tumour development and to assess its relationship to 
other markers, such as Rb and p53 proteins as well as the 
proliferative indices Ki-67 and PCNA. 
Materials and methods 
Formalin-fixed and paraffin-embedded tissues from 
34 cases of squamous cell carcinomas, 1 3  in situ 
carcinomas, 35 cases of dysplasia (as the only lesion or 
adjacent to the carcinomas), 10 papillomas and 17 cases 
of keratosis (material from our Pathology Laboratory) 
were exarnined. Paraffin sections adjacent and far from 
the tumour were used as controls. Histological slides 
from squamous cell carcinomas were reviewed and 
classified according to the standard criteria into well- 
moderately and poorly-differentiated carcinomas (grade 
1, 11, 111) with or without keratinization (Ferlito and 
Friedmann, 1993). Keratosis of the larynx is nearly 
synonymous with the process known as epithelial or 
squamous cell hyperplasia. Microscopically, keratotic 
lesions are characterized by hyperkeratotic epithelium 
(often with a granular layer) and acanthosis. Dysplasia 
refers to a microscopic change present in some cases of 
keratosis or papilloma (and sometimes independently of 
them), that is characterized by cellular atypia, loss of 
normal maturation and loss of stratification. According 
to the WHO Collaborating Center for the Histological 
classification of Upper Respiratory Tract Tumours, 
dysplasia was graded as mild, moderate or severe on the 
basis of the degree of nuclear abnormalities (including 
changes in polarity) and the leve1 of the epithelium 
showing loss of stratification (Shanmugaratnam and 
Sobin, 1991). Carcinoma in situ, like dysplasia, may be 
present as the only lesion or at the peripheral margins of 
an invasive carcinoma. The standard microscopic criteria 
for diagnosis are essentially the same as for its more 
common counterpart in the uterine cervix; that is, 
the presence of atypical changes throughout the 
epithelium without evidence of surface maturation 
(Shanmugaratnam and Sobin, 1991). However, some 
authors accept the diagnosis of in situ laryngeal 
carcinoma in the presence of surface maturation, in the 
form of keratinization, if nuclear atypia is prominent 
enough (Crissman et al., 1987). 
Immediately after excision, specimens were fixed in 
10 per cent neutral formalin, embedded in paraffin, cut at 
4 p m  and stained with haematoxylin and eosin for 
Table 1. Antibodies used. 
routine light microscopy. 
For immunohistochemical staining, additional 4 pm 
thick sections were cut from paraffin blocks. After 
blockage of endogenous peroxidase with H 2 0 2  in 
methanol for 30 minutes, sections were immersed in 
citrate buffer (pH 6.0) in a microwave-resistant 
container. The antibody sources and dilutions are shown 
in Table 1. Immunoperoxidase detection was employed 
using the ABC method (Dako) and diaminobenzidine 
substrate. Counter-staining was performed with 
haematoxylin. 
Appropriate positive and negative controls were 
used. 
Irnrnunohistochernical evaluation 
The evaluation of immunostaining (membrane 
cytoplasmic for CD44 or nuclear for Rb, p53, Ki-67 and 
PCNA) was calculated as the percentage of positive 
epithelial cells in relation to the total number of cells 
encountered in 20 representative high power fields. 
Every stained nucleus was considered positive, 
irrespective of intensity. Each sample was first scanned 
with a low magnification and at least 5 to 10 fields were 
assessed with a high power magnification. Al1 slides 
were reviewed and scored in a blind test by two 
pathologists. 
Statistical analysis 
The association of continuous variables was 
confirmed using nonparametric test for two or severa1 
independent samples or Spearman bivariable correlation. 
P-values smaller than 0.05 were considered statistically 
significant. 
Results 
CD44 immunostaining was detected on the cell 
surface (Fig. 1). In the «normal» appearing adjacent 
epithelium the cell surface CD44 immunoreactivity was 
confined to the basa1 part and was expressed in less than 
10% of cells in rnost cases. CD44 expression was 
detected in some lymphocytes and macrophages which 
were used as interna1 controls (Fig. 2). Nerves in the 
lamina propria also showed a strong staining of the 
myelin sheath (Schwann cells). For Rb, p53, Ki-67 and 
PCNA, labeling of a variable proportion of epithelial cell 
nuclei was observed in each case. In benign and 
premalignant lesions the immunostaining was usually 
ANTlBODlES SUPPLIER DlLUTlON INCUBATION TIME 
CD44 (Clone DF 1485) Dako 1 :40 overnight* 
DO-7 (IgG2b) Ylern 1 : 200 overnight* 
Anti-Rb (AB-5) Oncogene 1 : 80 overnight* 
Ki-67 Dako 1: 10 30 rnin 
PC-10 Dako 1: 50 One hour 
*: with rnicrowave oven antigen retrieval 
Table 2. CD44 expression in benign, prernalignant and rnalignant 
epithelial lesions of the larynx. 
Ca IN SlTU DYSPLASIA PAPILLOMA KERATOSIS 
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detected at the basa1 portion of the laryngeal epithelium. @=0.016) (Table 3). Both pRb and PCNA as well as Ki- 
The mean value of CD44 expression was 78.84 in 67 expression increased statistically on progression to 
squarnous cell carcinomas, 78.04 in in situ carcinomas, hyperplastic to premalignant and malignant lesions. The 
54.93 in epithelial dysplasias, 26.8 in papillomas and 
24.97 in keratosis. CD44 protein expression was 
detected in 81.8% (>lo% of positive neoplastic cells) 0f Table 3. CD44 glycoprotein expression in correlation with RB, p53, Ki- 
the squamous cell carcinomas, Rb protein in 69.7% 67 and PCNA in squamous cell carcinomas. 
(>5% of positive neoplastic ceils) and p53 in 40% (>5% 
of positive neoplastic cells). CD44 expression was CD44 EXPRESSION 
gradually increased from keratosis, papillomas and 40% >lo% p value 
dysplasias through carcinomas (Table 2). No statistically Rb 
significant correlation of CD44 expression between in <5 3 7 p-0.011 
situ and invasive carcinomas was found. However, a >5 3 20 
strong difference of reaction between carcinomas and the 
~ 5 3  
other studied groups was observed. In the cases of <5 3 18 
epithelial dysplasia, CD44 levels were quite higher than >5 3 8 
in cases of keratosis (p<0.0001) or papillomas @=0.01). ~ i - 6 7  
We did not find any statistically significant difference of <5 3 8 
CD44 expression between papillomas and keratosis. In >5 3 18 
the group of invasive carcinomas, CD44 expression was PCNA 
statistically correlated with pRb (p=0.011), while in <50 3 8 NS 
preinvasive in situ lesions it was correlated with PCNA >50 3 19 
Flg. l. lntense cell membrane immunoreacüvity for CD44 in the majority oi tumour cells in a case of moderate drfferentiated squslmous cell carcinoma. 
ABC, x 200 
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relationship of CD44 immunoreactivity with the degree 
of dysplasia, the grade of carcinoma and p53 protein 
expression was insignificant. 
Discussion 
Knowledge of molecular mechanisms in cell-cell 
and cell-matrix adhesion has increased dramatically 
during the past decade. Adhesive and dishesive forces 
between tumour cells and neighbouring elements, such 
as matrix and endothelium, determine invasion and 
metastasis. Since adhesion molecules actively participate 
in the arrest and transmigration of inflammatory and 
tumour cells, they constitute a possible target for 
therapeutic intervention. 
The traditional prognostic factors, including stage of 
disease and tumor grade, have shown a limited 
prognostic significance and an inability to predict 
clinical response to specific treatment in patients with 
laryngeal squamous-cell carcinoma. Recent basic 
discoveries about the biological significance of nuclear 
and cell-surface marker proteins have opened new areas 
of research into head and neck cancer. However, the 
clinical significance of these markers is not yet clearly 
understood. 
CD44 is a cell membrane glycoprotein, the function 
of which has been hypothesized to be related to its action 
as a cell hyaluronate receptor (Hallen et al., 1996). 
Overexpression of CD44 has been found in various types 
of human tumours and is supposed to be implicated in 
tumour progression (Wielenga et al., 1993; Fox et al., 
1994). 
In laryngeal squamous cell carcinomas the role of 
CD44 expression is not clearly known and is relatively 
controversial. It has been reported that loss of cell 
adhesion implied by decreased expression of CD44, 
correlates with an increase in metastasis and a shorter 
patient survival (Spafford et al., 1996). There are also 
studies in which CD44 expression does not appear to be 
a strong connection to the metastatic behavior (Ostwald 
et al., 1997). 
In this work, we studied the immunohistochemical 
Flg. 2. A case of moderate dysplasia exhibiing CD44 protein expression at the lower part of the epithelium. Normal lyrnphocytes are also positive in the 
substrate. ABC, x 100 
1117 
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expression of CD44 in a ser ies  of hyperplastic,  
premalignant and malignant lesions of the larynx, in an 
attempt to elucidate the role of this molecule in the 
development and progression of laryngeal carcino- 
genesis. 
CD44 was recognized in al1 lesions and its 
expression was gradually statistically increased from 
keratosis, papillomas and dysplastic lesions to in situ or 
invasive carcinomas. A strong statistical difference of 
CD44 expression between carcinomas (in situ and 
invasive) and the other studied groups was observed. In 
addition, in dysplastic lesions, CD44 expression was 
higher than in hyperplastic lesions without dysplasia. 
The obse~a t ion  of this progressive expression suggests 
that CD44 rnay be involved at the developmental stage 
of laryngeal carcinogenesis. However, CD44 expression 
was not correlated with the histological grade of both 
benign and malignant epithelial lesions. 
Rb is a tumour suppressor gene and loss of its 
functioning protein suggests that it plays a growth 
regulatory role in many, if not all, cell types. In addition, 
this loss rnay contribute to the formation of many types 
of tumours. To our knowledge, the role of Rb in 
laryngeal lesions has not been studied extensively and in 
the already existing reports there is controversia1 
information. It has been shown that inactivation of Rb 
protein is involved in the carcinogenesis of head and 
neck lesions at al1 levels of the process of protcin 
expression: DNA, mRNA and protein (Yokoyama et al., 
1996). On the other hand, there are findings which 
suggest that the expression of Rb protein than the loss of 
its expression correlates with the presence of metastasis 
in patients with laryngeal carcinoma (Takes et al., 1997). 
In the current study, we found a high expression of Rb 
protein in malignant lesions (in situ and invasive 
carcinomas), a lower one in lesions with various degrees 
of dysplasia and enough lower in the other examined 
lesions without dysplasia the difference being 
statistically significant. This  unexpected f inding 
probably mean that Rb protein expression rnay be related 
to the progression of the stage of laryngeal lesions. 
Furthermore, w e  observed a statistically positive 
correlation between Rb and CD44 expression in the 
series of invasive carcinomas. These results indicate that 
the simultaneous positivity of these two markers rnay 
provide preliminary information about the selection 
advantage of the tumour cells. 
It is known that p53 gene is a tumour suppressor 
gene negatively regulating the cell  cycle and that 
mutation of this gene is  the most common genetic 
alteration in human tumours (Levine et al., 1994; Soussi 
et al., 1994). With regard to laryngeal squamous cell 
cancer, there are studies which report that abnormalities 
of p53 gene occur more frequently than in adeno- 
carcinomas (Sakai et al., 1992). In addition, an increased 
expression of p53 and decreased patient survival have 
been reported in the late stages of squamous cell 
carcinomas (Spafford et al., 1996). Other investigations 
indicated that positive p53 immunostaining could be 
demonstrated early in the development of carcinomas. In 
fact, p53 expression has been reported to be present in 
normal mucosa and in dysplastic mucosa adjacent to the 
tumours (Dolcetti et  al., 1992), as  well as  in pre- 
malignant lesions of the larynx (Shin et al., 1994). In our 
study we found that p53 was expressed in al1 studied 
cases suggesting that changes in the p53 gene and its 
protein product rnay play a role from the early phase of 
laryngeal tumourogenesis. While an inverse relationship 
has been reported between p53 and CD44 expression 
(Spafford et al., 1996), we did not find any correlation 
between these markers. 
Both PCNA and Ki-67 antigens are nuclear proteins 
that function in the active phases of the cell cycle. Their 
expression is considered a measure of tumour 
proliferative activity. High PCNA and Ki-67 indices 
have correlated with aggressive behavior in tumours of 
various sites (Hall et a1.,1990; Kearsley et al., 1990). In 
patients with laryngeal squamous cell carcinomas there 
are data which indicate that cell proliferative indices 
rnay be considered as  reliable and reproducible 
indicators of biological aggressiveness (Munck-Wikland 
et al., 1994). In addition, studies analyzing the proli- 
ferative activity of epithelial cells in benign epithelial 
hyperplastic lesions conclude that the proliferative 
fraction progressively increases with the degree of 
epithelial hyperplasia, suggesting that the degree of 
proliferative dysregulation might be used as a prognostic 
marker for revealing the highest risk of progress to overt 
carcinoma (Coltera et al., 1992; Zidar et al., 1996). In 
our study, we found a strong statistically significant 
difference for Ki-67 and PCNA between malignant, 
premalignant and hyperplastic lesions, reaching the 
highest value in the in situ and invasive carcinomas. In 
addition, w e  observed a statistically significant 
correlation between CD44 and PCNA only in the cases 
of in situ carcinomas. We suggest that the enhanced leve1 
of CD44 in laryngeal lesions is asynchronous with cell 
proliferation and does not directly link with it. 
In conclusion, CD44 expression rnay be involved in 
the complex mechanism of the development and 
progression of laryngeal lesions. With the application of 
this observation in the clinical practice, we might obtain 
preliminary information and predict the biological 
behavior of these lesions. Determination of both CD44 
and Rb expressions rnay prove useful in assessing which 
patients, especially with premalignant lesions, are at 
greatest risk of progressing to cancer and who would 
therefore benefit from intensive surveillance. 
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